News LCT and The Bionic Ear Institute Announce Agreement to Improve Hearing Loss Living Cell Technologies Limited (ASX: LCT) has entered into a collaborative agreement with The Bionic Ear Institute an internationally recognised not-for-profit biomedical research organisation, to improve the hearing outcomes for cochlear implant patients through rehabilitation of the auditory nerve. Related Document |